Physician profile
Ernst Nicolitz
NPI 1275512394
$1,378.23
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $554 · 2020: $677 · 2021: $86.03 · 2022: $61.30.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $525.68 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $175.52 | 2019-2022 | |
| Sight Sciences, INC. | $150.93 | 2019-2021 | |
| Allergan, INC. | $150.84 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $101.93 | 2019-2021 | |
| Alcon Vision LLC | $66.39 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Novartis Pharmaceuticals Corporation | $46.98 | 2019-2020 | |
| Shire North American Group INC | $27.77 | 2019 | |
| Mallinckrodt Enterprises LLC | $19.63 | 2019 | |
| Glaukos Corporation | $17.91 | 2019 | |
| Horizon Therapeutics Plc | $17.14 | 2019 | |
| Eyevance Pharmaceuticals LLC | $12.80 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernst Nicolitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.